BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 25279444)

  • 1. Synthesis and preclinical evaluation of 2-(2-furanyl)-7-[2-[4-[4-(2-[11C]methoxyethoxy)phenyl]-1-piperazinyl]ethyl]7H-pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidine-5-amine ([11C]Preladenant) as a PET tracer for the imaging of cerebral adenosine A2A receptors.
    Zhou X; Khanapur S; Huizing AP; Zijlma R; Schepers M; Dierckx RA; van Waarde A; de Vries EF; Elsinga PH
    J Med Chem; 2014 Nov; 57(21):9204-10. PubMed ID: 25279444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In Vivo Evaluation of
    Zhou X; Boellaard R; Ishiwata K; Sakata M; Dierckx RAJO; de Jong JR; Nishiyama S; Ohba H; Tsukada H; de Vries EFJ; Elsinga PH
    J Nucl Med; 2017 May; 58(5):762-767. PubMed ID: 28062599
    [No Abstract]   [Full Text] [Related]  

  • 3. Synthesis and in vivo Evaluation of Fluorine-18 and Iodine-123 Pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidine Derivatives as PET and SPECT Radiotracers for Mapping A2A Receptors.
    Vala C; Morley TJ; Zhang X; Papin C; Tavares AA; Lee HS; Constantinescu C; Barret O; Carroll VM; Baldwin RM; Tamagnan GD; Alagille D
    ChemMedChem; 2016 Sep; 11(17):1936-43. PubMed ID: 27407017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of [18F]-labeled pyrazolo[4,3-e]-1,2,4- triazolo[1,5-c]pyrimidine (SCH442416) analogs for the imaging of cerebral adenosine A2A receptors with positron emission tomography.
    Khanapur S; Paul S; Shah A; Vatakuti S; Koole MJ; Zijlma R; Dierckx RA; Luurtsema G; Garg P; van Waarde A; Elsinga PH
    J Med Chem; 2014 Aug; 57(15):6765-80. PubMed ID: 25061687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Initial Evaluation of an Adenosine A
    Sakata M; Ishibashi K; Imai M; Wagatsuma K; Ishii K; Zhou X; de Vries EFJ; Elsinga PH; Ishiwata K; Toyohara J
    J Nucl Med; 2017 Sep; 58(9):1464-1470. PubMed ID: 28280214
    [No Abstract]   [Full Text] [Related]  

  • 6. Characterization of the potent and highly selective A2A receptor antagonists preladenant and SCH 412348 [7-[2-[4-2,4-difluorophenyl]-1-piperazinyl]ethyl]-2-(2-furanyl)-7H-pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidin-5-amine] in rodent models of movement disorders and depression.
    Hodgson RA; Bertorelli R; Varty GB; Lachowicz JE; Forlani A; Fredduzzi S; Cohen-Williams ME; Higgins GA; Impagnatiello F; Nicolussi E; Parra LE; Foster C; Zhai Y; Neustadt BR; Stamford AW; Parker EM; Reggiani A; Hunter JC
    J Pharmacol Exp Ther; 2009 Jul; 330(1):294-303. PubMed ID: 19332567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo evaluation of [
    Zhou X; Khanapur S; de Jong JR; Willemsen AT; Dierckx RA; Elsinga PH; de Vries EF
    J Cereb Blood Flow Metab; 2017 Feb; 37(2):577-589. PubMed ID: 26917190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preclinical Evaluation and Quantification of
    Khanapur S; van Waarde A; Dierckx RA; Elsinga PH; Koole MJ
    J Nucl Med; 2017 Mar; 58(3):466-472. PubMed ID: 27789720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, synthesis, and biological evaluation of C9- and C2-substituted pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidines as new A2A and A3 adenosine receptors antagonists.
    Baraldi PG; Fruttarolo F; Tabrizi MA; Preti D; Romagnoli R; El-Kashef H; Moorman A; Varani K; Gessi S; Merighi S; Borea PA
    J Med Chem; 2003 Mar; 46(7):1229-41. PubMed ID: 12646033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiation Dosimetry of a Novel Adenosine A
    Zhou X; Elsinga PH; Khanapur S; Dierckx RA; de Vries EF; de Jong JR
    Mol Imaging Biol; 2017 Apr; 19(2):289-297. PubMed ID: 27539309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [In vivo investigation of the A2A adenosine receptor distribution using the [11C]-CSC radioligand].
    Boros I; Lengyel Z; Balkay L; Horváth G; Szentmiklósi AJ; Fekete I; Márián T
    Orv Hetil; 2002 May; 143(21 Suppl 3):1317-9. PubMed ID: 12077927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 11C-labeled KF18446: a potential central nervous system adenosine A2a receptor ligand.
    Ishiwata K; Noguchi J; Wakabayashi S; Shimada J; Ogi N; Nariai T; Tanaka A; Endo K; Suzuki F; Senda M
    J Nucl Med; 2000 Feb; 41(2):345-54. PubMed ID: 10688121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Occupancy of adenosine A
    Ishibashi K; Miura Y; Wagatsuma K; Toyohara J; Ishiwata K; Ishii K
    Neuropharmacology; 2018 Dec; 143():106-112. PubMed ID: 30253174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Small-animal PET study of adenosine A(1) receptors in rat brain: blocking receptors and raising extracellular adenosine.
    Paul S; Khanapur S; Rybczynska AA; Kwizera C; Sijbesma JW; Ishiwata K; Willemsen AT; Elsinga PH; Dierckx RA; van Waarde A
    J Nucl Med; 2011 Aug; 52(8):1293-300. PubMed ID: 21764782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo imaging of adenosine A2A receptors in rat and primate brain using [11C]SCH442416.
    Moresco RM; Todde S; Belloli S; Simonelli P; Panzacchi A; Rigamonti M; Galli-Kienle M; Fazio F
    Eur J Nucl Med Mol Imaging; 2005 Apr; 32(4):405-13. PubMed ID: 15549298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and in vivo evaluation of [11C]SN003 as a PET ligand for CRF1 receptors.
    Kumar JS; Majo VJ; Sullivan GM; Prabhakaran J; Simpson NR; Van Heertum RL; Mann JJ; Parsey RV
    Bioorg Med Chem; 2006 Jun; 14(12):4029-34. PubMed ID: 16529935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of distribution of adenosine A2A receptors in normal human brain measured with [11C]TMSX PET.
    Mishina M; Ishiwata K; Kimura Y; Naganawa M; Oda K; Kobayashi S; Katayama Y; Ishii K
    Synapse; 2007 Sep; 61(9):778-84. PubMed ID: 17568431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adenosine 2A receptor occupancy by tozadenant and preladenant in rhesus monkeys.
    Barret O; Hannestad J; Alagille D; Vala C; Tavares A; Papin C; Morley T; Fowles K; Lee H; Seibyl J; Tytgat D; Laruelle M; Tamagnan G
    J Nucl Med; 2014 Oct; 55(10):1712-8. PubMed ID: 25082853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 2-(2-Furanyl)-7-phenyl[1,2,4]triazolo[1,5-c]pyrimidin-5-amine analogs: highly potent, orally active, adenosine A2A antagonists. Part 1.
    Matasi JJ; Caldwell JP; Zhang H; Fawzi A; Cohen-Williams ME; Varty GB; Tulshian DB
    Bioorg Med Chem Lett; 2005 Aug; 15(16):3670-4. PubMed ID: 15978806
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.